Multicomponent Test Tops PSA for Clinically Significant Prostate Cancers

(MedPage Today) — A multicomponent blood-based biomarker test that combines prostate-specific antigen (PSA) with additional plasma protein biomarkers, a polygenic risk score, and clinical variables identified more clinically significant prostate…